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Previously, we have shown that SH-SY5Y cells exposed to high concentrations of methadone died due to a necrotic-like cell
death mechanism related to delayed calcium deregulation (DCD). In this study, we show that, in terms of their Ca2+ responses
to 0.5mM methadone, SH-SY5Y cells can be pooled into four diﬀerent groups. In a broad pharmacological survey, the relevance
of diﬀerent Ca2+-related mechanisms on methadone-induced DCD was investigated including extracellular calcium, L-type Ca2+
channels, μ-opioid receptor, mitochondrial inner membrane potential, mitochondrial ATP synthesis, mitochondrial Ca2+/2Na+-
exchanger, reactive oxygen species, and mitochondrial permeability transition. Only those compounds targeting mitochondria
such as oligomycin, FCCP, CGP 37157, and cyclosporine A were able to amend methadone-induced Ca2+ dyshomeostasis
suggesting that methadone induces DCD by modulating the ability of mitochondria to handle Ca2+. Consistently, mitochondria
became dramatically shorter and rounder in the presence of methadone. Furthermore, analysis of oxygen uptake by isolated rat
liver mitochondria suggested that methadone aﬀected mitochondrial Ca2+ uptake in a respiratory substrate-dependent way. We
conclude that methadone causes failure of intracellular Ca2+ homeostasis, and this eﬀect is associated with morphological and
functional changes of mitochondria. Likely, this mechanism contributes to degenerative side eﬀects associated with methadone
treatment.
1. Introduction
Methadone (D,L-methadone hydrochloride) is frequently
used in diﬀerent therapies including opioid addiction [1],
long-lasting analgesics in cancer and neuropathic pain
syndromes [1–3]. However, numerous reports indicate a
negative impact on human cognition by chronic exposure to
opioid drugs. Patients subjected to methadone maintenance
programs show impaired cognitive abilities in aspects such
as psychomotor performance, information processing, atten-
tion, problem solving, memory, decision making, reaction
time, and emotional facial expression recognition [4–10].
Changes in the cytosolic free-calcium concentration
([Ca2+]cyt) are involved in control of a large number
of cellular and physiological processes including neuronal
excitability, synaptic plasticity, and gene transcription [11,
12]. However, the physiological Ca2+ signal can switch to
a death signal when the [Ca2+]cyt increases dramatically.
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For example, excitotoxic high glutamate concentrations
result in an initial transient increase in [Ca2+]cyt that is
followed by a delayed, irreversible rise in [Ca2+]cyt known as
delayed calcium deregulation (DCD). Although several steps
preceding DCD remain to be clarified, there is evidence that
DCD is the irreversible end point of a sequence involving
mitochondrial Ca2+ overloading. DCD precedes and reliably
predicts the necrotic death of cultured neurons [13].
Mitochondria are important for cellular Ca2+ home-
ostasis. They buﬀer variations in Ca2+ concentrations by
taking up Ca2+ when and where [Ca2+]cyt levels are passing
a threshold level above which the mitochondrial Ca2+
uniporter is activated, and slowly release Ca2+ back to
the cytosol when [Ca2+]cyt drop below this point [14].
Mitochondrial Ca2+ overload, if large and sustained enough,
may contribute tomitochondria permeability transition pore
(MPTP) formation and ultimately lead to cell death [11,
15]. Because, mitochondria may accumulate a considerable
amount of Ca2+ during neurotoxic exposure, a possibility is
that DCD may represent the final consequence of mitochon-
drial Ca2+ overload. MPTP is a large, proteinaceous, Ca2+-
activated, proton- and ADP-inhibited voltage-dependent
pore. It spans the inner and outer mitochondrial membrane
allowing the passage of ions and substrates less than 1.5 kDa.
Characteristically, opening of the MPTP is inhibited by
cyclosporin A [16, 17].
SH-SY5Y cells are considered a suitable model for
investigating opioid-mediated responses in neurons. These
cells express both μ- and δ-opioid receptors [18]. In previous
studies, we showed that SH-SY5Y cells exposed to high
concentrations of methadone (0.5mM) died through a
necrotic-like cell death mechanism and that methadone
may induce changes in the [Ca2+]cyt [19, 20]. However, the
underlying mechanisms causing alterations of the [Ca2+]cyt
in SH-SY5Y cells in the presence of methadone remained
unknown. Therefore, the aim of the present study was to
investigate those mechanisms. A clear understanding of the
factors that mediate this phenomenon might help to resolve
the mechanisms that promote neuronal cell death during
methadone-induced cognitive damage.
2. Material and Methods
2.1. Cells Cultures. SH-SY5Y cells (ATCC) were plated at
a density of 5.3 × 104 cells/cm2 on μ-Dish 35mm High
IbiTreat (ibidi GmbH, Martinsried, Mu¨nchen, Germany) as
previously reported [21].
2.2. Calcium Measurements. Changes in [Ca2+]cyt in SH-
SY5Y cells were measured by loading cells with the cal-
cium probe Fura2/AM and using an inverted fluorescence
microscope (Nikon Eclipse TE2000-S) as described elsewhere
[22]. Cells were perfused with a medium containing 140mM
NaCl, 5mM KCl, 1mM MgCl2, 2.5mM CaCl2, 10mM
Hepes, and 11mM Glucose, pH 7.35. Ratios of fluorescence
emission excited at 340 and 380 nm were captured every 5
seconds [22]. Methadone or other compounds were added
from 1000x stock solutions to reach the appropriate final
concentrations. The eﬀects of selected compounds were
tested on [Ca2+]cyt in the absence and the presence of 0.5mM
methadone in diﬀerent sets of cells. Cells were pooled
according to the dynamics of the rises in [Ca2+].
2.3. Mitochondrial Morphology. To directly visualize mito-
chondrial morphology changes in intact cells overexpressing
pDsRed2-mito plasmid (Clontech Laboratories, Inc. Moun-
tain View, CA, USA) a Leica SP2 confocal microscope (63 ×
1.4NA objective) was used. For transfection of cells the
reagent Lipofectamine was used (Invitrogen, Carlsbad, CA,
USA) [23].
2.4. Mitochondria Isolation. Rat liver mitochondria were
isolated in MSH/EDTA and MSHmedia containing 210mM
mannitol, 70mM sucrose, 5mM Hepes, with or without
1mM EDTA, pH 7.4, by diﬀerential centrifugation according
to the standard procedure [24]. Mitochondrial protein
concentration was measured using the Micro BCA Protein
Reagent Kit. The mitochondrial suspensions were kept on ice
and immediately used for measurements of oxygen-uptake
rate.
2.5. Mitochondrial Oxygen Uptake. The rate of oxygen
uptake of isolated rat liver mitochondria was measured at
37◦C in a water-thermostatized incubation chamber with
a computer-controlled Clark-type O2 electrode (Oxygraph,
Hansatech, UK) in 0.5ml incubation buﬀer (145mM KCl,
30mMHepes, 5mMKH2PO4, 3mMMgCl2, 0.1mM EGTA,
0.1% defatted BSA, pH 7.4). The respiratory substrates
used were complex I- or complex II-linked, 2.5mM glu-
tamate/2.5mM malate or 5mM succinate in the presence
of 2 μM rotenone. The following additions were applied:
250 μM ADP, 200 μM CaCl2, 0.4 μM FCCP, and 0.5mM
methadone. For estimating mitochondrial Ca2+ uptake in
isolated mitochondria a Ca2+ index was calculated, which
denotes the ratio of oxygen-uptake rate triggered by addition
of 200 μM Ca2+ to previous oxygen uptake rate.
3. Results and Discussion
In this study, we have investigated the mechanisms involved
in methadone-induced rises in [Ca2+]cyt in SH-SY5Y cells.
Consistent with previous observations from our laboratory
[19] and other data [25], methadone induced a rise in
[Ca2+]cyt in most of the SH-SY5Y cells. However, the eﬀect
of methadone diﬀered considerably across cells. Analysis
of the dynamics of the [Ca2+]cyt recordings in the absence
and the presence of methadone suggested that four diﬀerent
types of calcium recordings can be observed in SH-SY5Y
cells. Figure 1(a) shows typical examples of recordings. For
the first group of cells no rise in [Ca2+]cyt was observed
during the entire period (30min) of measurements (type
1). A second group of cells was unable to regulate [Ca2+]cyt
homeostasis shortly after the addition of methadone (type
2) and [Ca2+]cyt increased continuously. A third group
displayed [Ca2+]cyt deregulation with a delay of 15–20
minutes (type 3). Finally, the fourth group was able to
control [Ca2+]cyt after an initial increase (type 4). Groups
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Figure 1: Methadone induces Ca2+ dyshomeostasis. (a). Eﬀects of 0.5mM methadone on [Ca2+]cyt in SH-SY5Y cells. Representative
recordings of the four diﬀerent types of response including no [Ca2+]cyt increase (type 1), early [Ca2+]cyt sustained increase (type 2), delayed
[Ca2+]cyt increase (type 3), and transient [Ca2+]cyt increase (Type 4). (b)-(c)Relative abundance (%) of SH-SY5Y cells that display type 2 (b)
or type 3 (c) recordings without (Control) and withmethadone treatment (Veh). Also shown are the eﬀects of several treatments on the above
mentioned relative abundance. Treatments include removal of extracellular calcium (0Ca), L-type Ca2+ channel blocker Nifedipine (2 μM);
opioid receptor antagonist Naloxone (50 μM), mitochondrial uncoupler FCCP (1 μM); ATP synthase inhibitor oligomycin (10 μg/ml),
mitochondria Na+/Ca2+ exchanger CGP37157 (25 μM); superoxide dismutase mimetic TEMPOL (0.2 μM) orMPTP antagonist cyclosporine
A (1 μM, CsA). All treatments were performed 5 min prior to addition of 0.5mM methadone. Data represent results obtained in at least 3
independent experiments. ∗P < 0.05; Student’s t-test versus basal conditions, (Veh).
1 and 4 represent, respectively, nonresponsive of cells and
cells responding with transient rise in [Ca2+]cyt and amount
20.82 and 31.38% of the cells. However, types 2 and 3
displayed short or delayed continuous rise in [Ca2+]cyt that
may be considered as early or delayed Ca2+ deregulation
according to the literature [26–29]. The abundance of cells
showing deregulation (type 2 and type 3) amount to 32.83
and 14.92%, of the total, respectively.
We have analyzed the relative abundance of the four
types of recordings described above in the absence (Control)
and the presence (Methadone) of 0.5mM methadone. The
results obtained are shown in Figures 1(b) and 1(c). Clearly,
methadone decreased type 4 (transient responsive cells) and
increased types 2 and 3 (deregulated cells). These results
suggest that methadone may induce a short or delayed Ca2+
deregulation in SH-SY5Y cells.
The mechanisms underlying the observed quantita-
tive changes in the types of Ca2+ responses mediated
by methadone are unknown. Therefore, we performed a
comprehensive pharmacological survey to study the possible
contribution of diﬀerent Ca2+ related mechanism to the
response to methadone. As illustrated in Figures 1(b) and
1(c) and discussed below, a 5min pretreatment of SH-
SY5Y cells with diﬀerent conditions and drugs aﬀected
the methadone-induced [Ca2+]cyt response, monitored as
changed frequencies of the diﬀerent types of the responses.
We found that in the absence of extracellular calcium
(0Ca) no change in responses to methadone was observed
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(n = 291 cells). These results suggest that Ca2+ entry
does not contribute to the reported changes in [Ca2+]cyt.
To confirm that extracellular Ca2+ was not involved in these
responses we tested the eﬀect ofmethadone in the presence of
nifedipine, a specific isopropyl L-type Ca2+ channel blocker.
Nifedipine (2 μM) did not modify the eﬀects of methadone
on the [Ca2+]cyt in SH-SY5Y cells (n = 226 cells). So, we
ruled out the involvement of this voltage-dependent channel
family in methadone-induced [Ca2+]cyt variations. We asked
then whether intracellular Ca2+ stores could contribute to the
responses tomethadone. Cells were treated with thapsigargin
(1–100 μM). To deplete intracellular Ca2+ stores before
methadone treatment. As expected, thapsigargin induced a
significant release in Ca2+ from the endoplasmic reticulum,
causing a transient increase in the [Ca2+]i that failed to
returned to the basal level within a 10-minute period.
A detailed observation of the methadone induced rise in
[Ca2+]i shows that cell responses were partially aﬀected by
this treatment, suggesting that the rise in calcium is partially
due to release from thapsigargin-sensitive, intracellular Ca2+
stores (n = 146 cells). We found that in untreated cells
addition of thapsigargin induced a transient increase in
[Ca2+] that has been attributed to a leakage of Ca2+ from
the endoplasmic reticulum. This eﬀect of thapsigargin alone
interferes the interpretation of the type 2 and 3 responses
after methadone addition (data not shown).
Another possible mechanism is the activation of endoge-
nous opioid receptors. To test this possibility, we treated the
cells with 50 μM Naloxone), the competitive antagonist of
the μ-opioid receptor. We found that this treatment did not
modify the relative abundance of any of the four types of cell
populations (n = 80 cells, 4 exp). This result suggests that the
changes in [Ca2+]cyt and DCD induced by methadone in SH-
SY5Y cells are independent of opioid receptors. In agreement
with the lack of μ-opioid receptor participation as found
here, it has been reported that methadone-toxic pathways are
not mediated by μ receptors [19, 30–32].
To test the possible contribution of mitochondria
we used the mitochondrial uncoupler carbonyl cyanide
p-trifluoromethoxyphenylhydrazone (FCCP; 1 μM) Ca2+
uptake by mitochondria depends strongly on mitochondrial
potential (ΔΨm). It is well established that FCCP collapses
mitochondrial potential and abolishes the ability of mito-
chondria to take up Ca2+. We found that in untreated cells,
addition of FCCP induced a transient increase in [Ca2+]
that has been attributed to leakage of Ca2+ from depolarized
mitochondria. We found that FCCP induced a 44% decrease
in the appearance of type 2 cells whereas increased the
relative abundance of cells showing a type 3 response by
2.7-fold in FCCP (Figures 1(b)-1(c)). FCCP abolished the
presence of type 1 cells.
The above results suggest that mitochondria are likely
involved in the response to methadone. Nevertheless, it
must be taken into account that as the simple usage of
protonophores does not allow a clear-cut study of the role
of mitochondrial Ca2+ transport as they also may cause
a lowering of the ATP/ADP ratio, thereby aﬀecting ATP-
dependent Ca2+ pumps [14]. An approach that has been
previously exploited to investigate the role of mitochondria
in synaptosomal Ca2+ homeostasis involves inhibition of
mitochondrial ATP synthesis by oligomycin and application
of glycolysis as the source of ATP and independent manip-
ulation of ΔΨm with specific respiratory chain inhibitors
[33, 34]. Inhibition of ATP synthase by oligomycin pre-
vents mitochondrial oxidative phosphorylation, but unlike
protonophore addition, it does not cause hydrolysis of
cytoplasmically generated ATP. It has been reported that
DCD might result from a failure in Ca2+ extrusion caused
by cytoplasmic ATP depletion [26]. Therefore, we tested
the eﬀects of a short, 5min, incubation with 10 μg/ml
oligomycin on Ca2+ responses. Under these conditions,
oligomycin alone did not modify the [Ca2+]cyt responses
during the 30min recording period. However, oligomycin
did alter the [Ca2+]cyt responses to methadone. Specifically,
the abundance of SH-SY5Y cells showing a type 2 response
were increased whereas the pool of cells showing a DCD-
related type 3 response were lost. Additionally, oligomycin
induced a 3.3-fold increase in cells showing a type 4
response. To test further the contribution of mitochondria
we investigated the possible role of the mitochondrial
Ca2+/2Na+ exchanger. Mitochondrial Ca2+ eﬄux is normally
primarily regulated by a Ca2+/2Na+ exchanger. To block
mitochondrial Ca2+ exit we used CGP37157 (50 μM), an
inhibitor of the Ca2+/2Na+-exchanger. A five min exposure
of cells to CGP37157 significantly increased the proportion
of cells showing no rise in [Ca2+]cyt in response tomethadone
during the entire [Ca2+]cyt measurement period (type 1)
(data not shown) because CGP37157 resulted in a drastic
decrease in the population of cells showing either type 2
(74%) or type 3 (85%) responses. In addition, the relative
abundance of cells showing a type 1 response returned to the
value obtained in untreated cells. These results support data
suggesting the relevance of mitochondria in methadone-
induced DCD (Figures 1(b)-1(c)).
To test contribution of reactive oxygen species we used
the cell-permeable, small molecule compound TEMPOL (4-
hydroxy-2,2,6,6-tetramethylpiperidinyloxy) to mimic super-
oxide dismutase activity. In the presence of TEMPOL
(0.2 μM; n = 80 cells), cells responded to methadone in a
diﬀerent way. Specifically, TEMPOL decreased the number
of cells showing a type 2 response by ∼70%, whereas the
abundance of cells showing a type 3 response was largely
increased (3.5 fold). Types 1 and 4 were nearly not present.
Consistent with our results, Nicholls et al. [28] suggested that
enhanced ROS is a consequence rather than a cause of DCD.
In their studies, they applied a novel technique to monitor
the bioenergetic status of in situ mitochondria in cultured
neurons in a model of glutamate excitotoxicity. In agreement
with this, a general ineﬀectiveness of antioxidants to decrease
DCD in the presence of glutamate has been observed [35].
Finally, we tested the contribution of the mitochondrial
permeability transition (MPTP). Additional eﬄux of mito-
chondrial Ca2+ can occur by induction of MPTP formation,
which is dependent on the mitochondrial matrix Ca2+
concentration and can be inhibited by cyclosporine A [16,
17]. To evaluate MPTP participation we administered CsA
(1 μM). CsA diminished the occurrence of response type 2
by 36% (n = 89 cells) in cell cultures challenged with 0.5mM
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Figure 2: Methadone alters mitochondrial morphology. Morphology of methadone-treated cells was studied by confocal imaging of SH-
SY5Y cells transfected with the pDsRed2-mito vector. Twenty-four hours after transfection, cell cultures were incubated for 3 h in the absence
or presence of 0.25 or 0.5mM methadone. Shown are images of the representative mitochondrial morphology in non-treated cells (control,
(a)) or cells treated with methadone ((b), 0.25 mM; (c), 0.5mM). Scale bar indicates 10 μm. (d), The fractions of cells with filamentous,
intermediate or punctuate mitochondrial patterns were determined in at least 6 independent cultures. (∗P < 0.05; ∗∗∗P < 0.001; Student’s
t-test versus basal conditions as indicated.)
methadone. Moreover, consistent with the hypothesized role
of the pore in DCD, CsA induced a 2-fold increase in
cells showing type 4 response. However, interpretation of
these results is diﬃcult because CsA may also inhibit the
mitochondrial Ca2+ uniporter in some instances.
Taken together, our data indicate that only drugs aﬀect-
ing mitochondrial handling of Ca2+, such as oligomycin,
FCCP, CGP 37157, and cyclosporine A, were able to
modulate methadone-induced delayed calcium deregulation
in SH-SY5Y cells. We therefore conclude that methadone-
induced dyshomeostasis is caused by improper functioning
of mechanisms that directly control mitochondrial activity
rather than a participation of plasma membrane Ca2+
channels or opioid receptors.
Next, the eﬀect of methadone on mitochondrial mor-
phology was studied in SH-SY5Y cells transfected with
pDsRed2-mito. In untreated cultures, mitochondria pre-
sented a long and tubular morphology (Figure 2(a)), which
became dramatically shorter and rounder upon three hours
of methadone treatment (Figures 2(b)–2(d)). Cell counting
of the diﬀerent mitochondrial morphologies (filamentous,
mixed and fragmented) indicated that methadone, in a dose-
dependent manner, induced mitochondrial fragmentation
(Figure 2(d)). This eﬀect seems contradictory to our earlier
observations that methadone failed to induce mitochondrial
swelling in isolated rat liver mitochondria [19]. Possibly,
the fragmentation eﬀect of methadone on mitochondria
is mediated by calcium. In fact, our data support this
hypothesis, and indicate a role of DCD in methadone-
induced toxicity. In agreement with this, it has been reported
that the MPTP opens under pseudopathological conditions
with relatively high Ca2+ and low ATP concentrations [15]
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Figure 3: Methadone aﬀects mitochondrial Ca2+ uptake in a respiratory substrate-dependent way. Oxygen uptake by isolated liver
mitochondria was determined using a Clark electrode in the presence of 5mM succinate or 2.5mM glutamate/2.5mMmalate as substrates.
(a) Uncoupling capacity of FCCP and methadone. (b) The eﬀect of FCCP and methadone on Ca2+ uptake. (c) The eﬀect of Ca2+ uptake on
the uncoupling capacity of FCCP and methadone. Additions: 250μM ADP, 200μM CaCl2, 0.4μM FCCP, and 0.5mM methadone. Traces
shown are the means obtained from four independent mitochondria preparations. Numbers on the traces indicate respiration rates at 37◦C
in nmol oxygen·mg protein−1·min−1.
as was the case in our previous experiments with SH-SY5Y
cells [19]. The rupture of the mitochondrial membrane
caused by Ca2+ overload reduces the number of “healthy”
mitochondria and this will aﬀect crucial neuronal functions
including synaptic transmission and axonal transport.
Finally, the eﬀect of methadone on mitochondrial Ca2+
uptake was studied (Figure 3). We used a Clark electrode
and applied diﬀerent respiratory substrates, namely succi-
nate and glutamate/malate. The respiratory chain is less
dependent on the presence of ΔΨm for succinate than for
glutamate/malate. Methadone is known to cause uncoupling
[19]. Therefore, as a control, 0.4 μM FCCP was used because
this concentration of FCCP resulted in an increase of oxygen-
uptake rate comparable with the uptake rate calculated for
0.5mM methadone (Figure 3(a)). The calculated values of
the state U (uncoupled state) to state 4 (resting state) ratios
(U/4 ratios) were as follows: for succinate 2.8± 0.5 (+FCCP)
and 2.3 ± 0.4 (+methadone), and for glutamate/malate
2.1 ± 0.5 (+FCCP) and 2.5 ± 0.4 (+methadone). Then, we
checked the eﬀect of FCCP and methadone on Ca2+ uptake
by mitochondria (Figures 3(b) and 3(c)). For this purpose
a Ca2+ index was calculated, which denotes the ratio of
oxygen-uptake rate triggered by addition of 200 μM Ca2+
to previous oxygen uptake rate. The values of the Ca2+
index were as follows: for succinate 3.0 ± 0.7 (control),
1.7 ± 0.3 (+FCCP), and 1.7 ± 0.4 (+methadone), and for
glutamate/malate 4.8 ± 0.3 (control), 1.8 ± 0.4 (+FCCP),
and 1.9 ± 0.5 (+methadone). Thus, the eﬀects of FCCP and
methadone on Ca2+ uptake are comparable, although in the
presence of glutamate/malate the eﬀect appears to be much
more pronounced. This probably results from a stronger
uncoupling eﬀect of methadone on glutamate/malate access
to the respiratory chain and a consecutive additional impair-
ment of Ca2+ uptake. Therefore, the eﬀect of methadone
on Ca2+ uptake by mitochondria may be dependent on the
respiratory substrates. On the other hand, when the values of
the U/4 ratios calculated in the absence and presence of Ca2+
uptake were compared (Figures 3(a) and 3(c)), a distinctive
decrease was observed in traces recorded in the presence of
Ca2+ uptake (Figure 3(c)). The calculated values of U/4 ratio
decreased as follows: for succinate from 2.8± 0.5 to 2.0± 0.2
(+FCCP) and 2.3 ± 0.4 to 2.1 ± 0.3 (+methadone) and for
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glutamate/malate 2.1±0.5 to 1.9±0.3 (+FCCP) and 2.5±0.4
to 2.1 ± 0.2 (+methadone). This could be caused by the
reduction of a ΔΨ component of the protomotive force as
a result of Ca2+ uptake, leading to a decrease of uncoupling
capacity by FCCP and methadone.
The data presented indicate that methadone induces
DCD in SH-SY5Y cells by altering the capacity of mito-
chondria to handle calcium, and correlates with distinct
changes of mitochondrial morphology. These morphological
changes, in turn, can be associated with mitochondrial
damage and cell death. Interestingly, swollen mitochondria
have been observed in the context of neurodegenerative
diseases [36, 37]. An imbalance in mitochondrial Ca2+
homeostasis might be important for both early and late
stages of the observed side eﬀects and, perhaps account
for some of the observed clinical symptoms, for example,
memory impairment.
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